Talazoparib
| CAS No. | 1207456-01-6 |
|---|---|
| MDL No. | MFCD22666357 |
| MF | C19H14F2N6O |
| MW | 380.40 |
| InChI Key | HWGQMRYQVZSGDQ-HZPDHXFCSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Talazoparib is an orally available small molecule PARP inhibitor used as an antineoplastic agent for selected breast cancer cases. It is associated with moderate serum aminotransferase elevations and rare instances of clinically apparent acute liver injury.
| CAS No. | 1207456-01-6 |
|---|---|
| Product Name | Talazoparib |
Biological Targets
PARP2·PARP1
Associated Conditions
breast neoplasm·urothelial carcinoma·neoplasm·triple-negative breast cancer·breast carcinoma·
* The information provided here is compiled from public sources and is for reference only.
